NF2 and glioblastoma: Somatic loss of NF2 has also been implicated in spontaneous human OSAs, schwannomas, meningiomas, mesothelioma, glioblastoma, breast, colorectal, skin, clear renal cell, prostatic and hepatic carcinomas.